Tumor-associated CD75s- and iso-CD75s-gangliosides are potential targets for adjuvant therapy in pancreatic cancer. [electronic resource]
Producer: 20081022Description: 2464-75 p. digitalISSN:- 1535-7163
- Adenocarcinoma -- drug therapy
- Antibodies, Neoplasm -- blood
- Antigens, CD -- immunology
- Antineoplastic Agents -- therapeutic use
- Biomarkers, Tumor -- antagonists & inhibitors
- Chemotherapy, Adjuvant
- Chromatography, Thin Layer
- Gangliosides -- antagonists & inhibitors
- Humans
- Immunohistochemistry
- Microscopy, Fluorescence
- Pancreatic Neoplasms -- drug therapy
- Recombinant Proteins -- therapeutic use
- Ribosome Inactivating Proteins, Type 2 -- therapeutic use
- Sialyltransferases -- antagonists & inhibitors
- Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
- Toxins, Biological -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.